Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
Clinical trial NCT03710824 · COMPLETED
Trial details
- NCT number
- NCT03710824
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-28
- Primary completion
- 2023-02-22
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.